These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1728462)

  • 1. Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis.
    Levi M; Biemond BJ; van Zonneveld AJ; ten Cate JW; Pannekoek H
    Circulation; 1992 Jan; 85(1):305-12. PubMed ID: 1728462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody.
    Biemond BJ; Levi M; Coronel R; Janse MJ; ten Cate JW; Pannekoek H
    Circulation; 1995 Feb; 91(4):1175-81. PubMed ID: 7850956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D; Stassen JM; Verstraete M
    J Clin Invest; 1983 Feb; 71(2):368-76. PubMed ID: 6681615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivated recombinant plasminogen activator inhibitor-1 (rPAI-1) effectively prevents thrombolysis in vivo.
    Vaughan DE; Declerck PJ; Van Houtte E; De Mol M; Collen D
    Thromb Haemost; 1992 Jul; 68(1):60-3. PubMed ID: 1514173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop.
    Stringer HA; van Swieten P; Heijnen HF; Sixma JJ; Pannekoek H
    Arterioscler Thromb; 1994 Sep; 14(9):1452-8. PubMed ID: 8068607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
    Torr-Brown SR; Sobel BE
    Thromb Res; 1993 Dec; 72(5):413-21. PubMed ID: 8303684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel low-molecular-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and reduces postthrombolysis thrombus growth in rabbits.
    Friederich PW; Levi M; Biemond BJ; Charlton P; Templeton D; van Zonneveld AJ; Bevan P; Pannekoek H; ten Cate JW
    Circulation; 1997 Aug; 96(3):916-21. PubMed ID: 9264501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of plasminogen activator inhibitor type 1 activity in plasma by thrombosis and by thrombolysis.
    Fujii S; Abendschein DR; Sobel BE
    J Am Coll Cardiol; 1991 Nov; 18(6):1547-54. PubMed ID: 1939960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolism.
    Reilly CF; Fujita T; Hutzelmann JE; Mayer EJ; Shebuski RJ
    Circulation; 1991 Jul; 84(1):287-92. PubMed ID: 1905594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of clot-bound alpha 2-antiplasmin enhances in vivo thrombolysis.
    Reed GL; Matsueda GR; Haber E
    Circulation; 1990 Jul; 82(1):164-8. PubMed ID: 1694738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface.
    Braaten JV; Jerome WG; Hantgan RR
    Blood; 1994 Feb; 83(4):982-93. PubMed ID: 8111066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.
    Zhu Y; Carmeliet P; Fay WP
    Circulation; 1999 Jun; 99(23):3050-5. PubMed ID: 10368124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets and endothelial cells act in concert to delay thrombolysis--evidence from an in vitro model of the human occlusive thrombus.
    Hantgan RR; Jerome WG; Handt S
    Thromb Haemost; 1998 Mar; 79(3):602-8. PubMed ID: 9531049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term high-dose effect of lovastatin on thrombolysis by rt-PA in a human whole-blood in vitro clot model.
    Kandadai MA; Meunier J; Lindsell CJ; Shaw GJ; Elkind MS
    Curr Neurovasc Res; 2012 Aug; 9(3):207-13. PubMed ID: 22621227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus.
    Gold HK; Yasuda T; Jang IK; Guerrero JL; Fallon JT; Leinbach RC; Collen D
    Circulation; 1991 Jun; 83(6 Suppl):IV26-40. PubMed ID: 2040069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor type 1 in platelets induces thrombogenicity by increasing thrombolysis resistance under shear stress in an in-vitro flow chamber model.
    Hosokawa K; Ohnishi-Wada T; Sameshima-Kaneko H; Nagasato T; Miura N; Kikuchi K; Koide T; Maruyama I; Urano T
    Thromb Res; 2016 Oct; 146():69-75. PubMed ID: 27611498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis model.
    Spriggs D; Gold HK; Hashimoto Y; Van Houtte E; Vermylen J; Collen D
    Thromb Haemost; 1989 Feb; 61(1):93-6. PubMed ID: 2501892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.
    Colucci M; Paramo JA; Stassen JM; Collen D
    J Clin Invest; 1986 Jul; 78(1):138-44. PubMed ID: 3088040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of endothelial cell expression of the plasminogen activator inhibitor type 1 gene by thrombosis in vivo.
    Fujii S; Sawa H; Saffitz JE; Lucore CL; Sobel BE
    Circulation; 1992 Dec; 86(6):2000-10. PubMed ID: 1451272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.